Julie Khlevner, MD

Specialties:
Gastroenterology, Pediatric Gastroenterology, Pediatrics

More specialties
Accepting New Patients

Treats Children

Virtual Visits/Telehealth

Profile Navigation

Overview
Schedule an Appointment
Location(s)
Insurance Accepted
Credentials & Experience
Research

Overview

I am privileged to have achieved my lifelong goal of becoming a pediatric gastroenterologist, more specifically a pediatric neurogastroenterologist. I have a special interest and expertise in disorders of the gut-brain interaction, including motility disorders, which involve the movement of food through the GI tract, and functional disorders, which involve interactions between the brain and GI tract that affect motility. These conditions can be debilitating and yet they remain challenging to treat effectively.
My team and I evaluate and treat children and adolescents using advanced, state-of-the-art diagnostic and therapeutic techniques with multidisciplinary approach. Some of the conditions we treat are dysphagia, achalasia, gastroesophageal reflux disease, chronic nausea, gastroparesis, irritable bowel syndrome, chronic abdominal pain, severe constipation, fecal incontinence, and anorectal disorders.
We think of our patients and their problems holistically and take pride in developing personal connections with patients and their families. My goal is to deliver compassionate, respectful, evidence-based, and humanistic care to children with gastrointestinal diseases.
I co-direct many multidisciplinary clinics, including the Gastrointestinal Motility Center, Esophageal Atresia Clinic, Aerodigestive Program, and Congenital Diaphragmatic Hernia Program, and I work closely with pediatric surgeons, pulmonologists, cardiologists, ear nose throat (ENT) specialists, psychologists, and language pathologists to provide the most comprehensive care to children with complex GI medical conditions.
I also take great pride in educating medical students, residents, fellows, and other providers. I have mentored several GI fellows who have joined other institutions across the county and are currently working to establish multidisciplinary clinics and expand access to care for functional and motility disorders.
In addition to my clinical and education roles, my team and I conduct multiple clinical research projects focusing on functional and motility disorders. I work on clinical trials which allow our patients to have access to therapeutics that are not otherwise offered to children. This work has led to numerous presentations at national meetings and publications in high impact gastroenterology journals—all with the mission of improving children’s health and advancing the science of gastrointestinal motility and functional gastrointestinal diseases.

Areas of Expertise / Conditions Treated

Abdominal Pain
Bowel Problems
Constipation
Encopresis
Esophageal Atresia
Gastroesophageal Reflux Disease
Gastrointestinal Disorders
Irritable Bowel Syndrome (IBS)
Motility Disorder, Esophageal
Motility disorders of the bowel
Pediatric Gastrointestinal (GI) Endoscopy

Academic Appointments

Associate Professor of Pediatrics at CUMC

Administrative Titles

Director, Pediatric Gastrointestinal Motility Center

Hospital Affiliations

NewYork-Presbyterian Morgan Stanley Children's Hospital
NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

Female

Schedule an Appointment

Virtual Visits/Telehealth

Virtual Visits allow you to connect with your provider from the comfort, convenience, and safety of your own home.
Schedule Virtual Visit

Phone Appointments

New and Existing Patients: (212) 305-5903

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.
Connect Sign In

Location(s)

ColumbiaDoctors - 3019 Merrick Road
3019 Merrick Road

Wantagh, NY 11793





Open location in Google Maps



CUIMC/NewYork-Presbyterian Morgan Stanley Children's Hospital
3959 Broadway

New York, NY 10032





Open location in Google Maps

Insurance Accepted

Aetna

Aetna Signature Administrators
EPO
HMO
Medicare Managed Care
NYP Employee Plan
NY Signature
POS
PPO
Student Health

Affinity Health Plan

Essential Plan
Medicaid Managed Care

Amida Care

Special Needs

Cigna

EPO
Great West (National)
HMO
POS
PPO

Emblem/GHI

Medicare Managed Care
PPO

Emblem/HIP

ConnectiCare
EPO
Essential Plan
HMO
Medicaid Managed Care
Medicare Managed Care
POS
PPO
Select Care (Exchange)
Vytra

Empire Blue Cross/Blue Shield

EPO
HMO
Medicare Managed Care
PPO

Empire Blue Cross Blue Shield HealthPlus

Child/Family Health Plus
Essential Plan
Medicaid Managed Care

Fidelis Care

Child/Family Health Plus
Essential Plan
Medicaid Managed Care
Medicare Managed Care

Healthfirst

Child/Family Health Plus
Leaf (Exchange)
Medicaid Managed Care
Medicare Managed Care

Local 1199

Local 1199

MagnaCare (National)

MagnaCare

Medicare

Railroad
Traditional Medicare

Multiplan

Multiplan

MVP Health Care

Child/Family Health Plus
Essential Plan
HMO
Medicaid Managed Care

Oxford Health Plans

Freedom
Liberty

UnitedHealthcare

Compass (Exchange)
Empire Plan
HMO
Medicaid (Community Plan)
Medicare Managed Care
POS
PPO

VNSNY CHOICE

Medicare Managed Care
SelectHealth
Special Needs

WellCare

Medicaid Managed Care
Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Credentials & Experience

Education & Training

Internship: Jacobi Hospital - Albert Einstein College of Medicine
Residency: Jacobi Hospital - Albert Einstein College of Medicine
Fellowship: Stony Brook University Medical Center

Board Certifications

Pediatrics
Pediatric Gastroenterology

Honors & Awards

New York SuperDoctors Rising Star

Research

Clinical Trials

NCT02559570 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)
NCT02559817 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children, Ages 6 to 17 Years, A Multicenter, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation (IBS-C) (ie, Fulfill Rome III Criteria for Child/Adolescent IBS and Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation
COMPLETED
NCT02042183 A Multicentre, Randomised, Placebo-controlled, Double-blinded Study of the Efficacy, Safety, and Pharmacokinetics of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation
NCT02138136 A Multicentre, Long-term Safety, Efficacy, and Pharmacokinetics Study of Lubiprostone in Paediatric Subjects Aged ≥ 6 Years to < 18 Years With Functional Constipation


For a complete list of publications, please visit PubMed.gov